Literature DB >> 14561167

Probiotics and immune regulation of inflammatory bowel diseases.

Yingzi Cong1, Astrid Konrad, Nuzhat Iqbal, Charles O Elson.   

Abstract

Intestinal microflora play an important role in the pathogenesis of inflammatory bowel diseases (IBD). Certain probiotic bacteria provide beneficial effects for human health and intervention of IBD. Possible mechanisms underlying these effects are diverse and include many aspects of the interaction of the host with its commensal microflora, with immunological and non-immunological effects. This review paper will focus on the recent progress in the use of probiotics in the treatment of IBD, and discuss the potential immunological mechanisms underlying their effects, such as the modulation of mucosal T cell, B cell, epithelial cell, dendrtic cell, macrophage, nature killer cell, antibody, and cytokine responses.

Entities:  

Mesh:

Year:  2003        PMID: 14561167     DOI: 10.2174/1568010033484278

Source DB:  PubMed          Journal:  Curr Drug Targets Inflamm Allergy        ISSN: 1568-010X


  9 in total

1.  From cheese to pharma: a designer probiotic for IBD.

Authors:  Charles O Elson
Journal:  Clin Gastroenterol Hepatol       Date:  2006-07       Impact factor: 11.382

2.  Eubacterium limosum ameliorates experimental colitis and metabolite of microbe attenuates colonic inflammatory action with increase of mucosal integrity.

Authors:  Osamu Kanauchi; Masanobu Fukuda; Yoshiaki Matsumoto; Shino Ishii; Toyokazu Ozawa; Makiko Shimizu; Keiichi Mitsuyama; Akira Andoh
Journal:  World J Gastroenterol       Date:  2006-02-21       Impact factor: 5.742

3.  Recommendations for improved use of the murine TNBS-induced colitis model in evaluating anti-inflammatory properties of lactic acid bacteria: technical and microbiological aspects.

Authors:  Benoit Foligné; Sophie Nutten; Lothar Steidler; Véronique Dennin; Denise Goudercourt; Annick Mercenier; Bruno Pot
Journal:  Dig Dis Sci       Date:  2006-02       Impact factor: 3.199

4.  Identification of commensal bacterial strains that modulate Yersinia enterocolitica and dextran sodium sulfate-induced inflammatory responses: implications for the development of probiotics.

Authors:  Julia S Frick; Kerstin Fink; Frauke Kahl; Maria J Niemiec; Matteo Quitadamo; Katrin Schenk; Ingo B Autenrieth
Journal:  Infect Immun       Date:  2007-05-07       Impact factor: 3.441

5.  Probiotic preparation VSL#3 alters the distribution and phenotypes of dendritic cells within the intestinal mucosa in C57BL/10J mice.

Authors:  Xiao Wang; Maurice R G O'Gorman; Heng-Fu Bu; Viola Koti; Xiu-Li Zuo; Xiao-Di Tan
Journal:  J Nutr       Date:  2009-06-23       Impact factor: 4.798

Review 6.  Stem cells as potential therapeutic targets for inflammatory bowel disease.

Authors:  Udai P Singh; Narendra P Singh; Balwan Singh; Manoj K Mishra; Mitzi Nagarkatti; Prakash S Nagarkatti; Shree Ram Singh
Journal:  Front Biosci (Schol Ed)       Date:  2010-06-01

7.  Enhancement of Oral Tolerance Induction in DO11.10 Mice by Lactobacillus gasseri OLL2809 via Increase of Effector Regulatory T Cells.

Authors:  Ayako Aoki-Yoshida; Kiyoshi Yamada; Satoshi Hachimura; Toshihiro Sashihara; Shuji Ikegami; Makoto Shimizu; Mamoru Totsuka
Journal:  PLoS One       Date:  2016-07-29       Impact factor: 3.240

8.  The immunomodulatory effects of long-term supplementation with Lactobacillus casei Shirota depend on ovalbumin presentation in BALB/c mice.

Authors:  Li-Han Chen; Chun-Hsu Pan; Shih-Yi Huang; Ching-Hung Chan; Hui-Yu Huang
Journal:  Sci Rep       Date:  2021-09-30       Impact factor: 4.379

9.  Probiotic yogurt Affects Pro- and Anti-inflammatory Factors in Patients with Inflammatory Bowel Disease.

Authors:  Mahdi Shadnoush; Rahebeh Shaker Hosseini; Yadollah Mehrabi; Ali Delpisheh; Elham Alipoor; Zeinab Faghfoori; Nakisa Mohammadpour; Jalal Zaringhalam Moghadam
Journal:  Iran J Pharm Res       Date:  2013       Impact factor: 1.696

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.